Intermolecular, Inc.
IMI
IMI was delisted on the 19th of September, 2019.
26 hedge funds and large institutions have $24M invested in Intermolecular, Inc. in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 5 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
8% more funds holding
Funds holding: 24 → 26 (+2)
5% less capital invested
Capital invested by funds: $25.3M → $24M (-$1.34M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$533K |
| 2 |
EM
Emancipation Management
New York
|
+$285K |
| 3 |
HK
Horizon Kinetics
New York
|
+$142K |
| 4 |
Renaissance Technologies
New York
|
+$87.4K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$25.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPM
Symmetry Peak Management
Radnor,
Pennsylvania
|
-$945K |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$202K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$72.8K |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$51K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$41K |
IMI Hedge Fund Activity: Q1 2018 in Review
26 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q1 2018, worth a combined $24M — down 5.3% from $25.3M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new IMI positions and 5 closed out — a net gain of 2 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Barclays, opening a new position worth an estimated $533K. The largest seller was Symmetry Peak Management, cutting an estimated $945K.
- 26 institutional investors held Intermolecular, Inc. (IMI) as of Q1 2018, up from 24 in Q4 2017.
- Funds reported $24M of Intermolecular, Inc. stock for Q1 2018, down 5.3% quarter-over-quarter.
- 7 funds opened new Intermolecular, Inc. positions in Q1 2018 and 5 closed out, a net change of +2 holders.
- The largest Intermolecular, Inc. buyer in Q1 2018 was Barclays, an estimated $533K added.
- The largest Intermolecular, Inc. seller in Q1 2018 was Symmetry Peak Management, an estimated $945K sold.
Based on aggregated 13F filings for Q1 2018.